Poly(ADP-ribose) Polymerase Regulates Glycolytic Activity in Kidney Proximal Tubule Epithelial Cells

Overview

Journal Anat Cell Biol

Specialty Anatomy & Histology

Date 2016 Jul 7

PMID 27382509

Citations 10

Authors

Hana Song

Sang Pil Yoon

Jinu Kim

Affiliations

Soon will be listed here.

Abstract

After renal injury, selective damage occurs in the proximal tubules as a result of inhibition of glycolysis. The molecular mechanism of damage is not known. Poly(ADP-ribose) polymerase (PARP) activation plays a critical role of proximal tubular cell death in several renal disorders. Here, we studied the role of PARP on glycolytic flux in pig kidney proximal tubule epithelial LLC-PK1 cells using XFp extracellular flux analysis. Poly(ADP-ribosyl)ation by PARP activation was increased approximately 2-fold by incubation of the cells in 10 mM glucose for 30 minutes, but treatment with the PARP inhibitor 3-aminobenzamide (3-AB) does-dependently prevented the glucose-induced PARP activation (approximately 14.4% decrease in 0.1 mM 3-AB-treated group and 36.7% decrease in 1 mM 3-AB-treated group). Treatment with 1 mM 3-AB significantly enhanced the glucose-mediated increase in the extracellular acidification rate (61.1±4.3 mpH/min vs. 126.8±6.2 mpH/min or approximately 2-fold) compared with treatment with vehicle, indicating that PARP inhibition increases only glycolytic activity during glycolytic flux including basal glycolysis, glycolytic activity, and glycolytic capacity in kidney proximal tubule epithelial cells. Glucose increased the activities of glycolytic enzymes including hexokinase, phosphoglucose isomerase, phosphofructokinase-1, glyceraldehyde-3-phosphate dehydrogenase, enolase, and pyruvate kinase in LLC-PK1 cells. Furthermore, PARP inhibition selectively augmented the activities of hexokinase (approximately 1.4-fold over vehicle group), phosphofructokinase-1 (approximately 1.6-fold over vehicle group), and glyceraldehyde-3-phosphate dehydrogenase (approximately 2.2-fold over vehicle group). In conclusion, these data suggest that PARP activation may regulate glycolytic activity via poly(ADP-ribosyl)ation of hexokinase, phosphofructokinase-1, and glyceraldehyde-3-phosphate dehydrogenase in kidney proximal tubule epithelial cells.

Citing Articles

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions.

Medrano M, Contreras M, Caballero-Velazquez T, Martinez L, Bejarano-Garcia J, Calderon-Ruiz R Br J Cancer. 2024; 130(9):1529-1541.

PMID: 38461169 PMC: 11058274. DOI: 10.1038/s41416-024-02618-6.

The potential role of upregulated PARP-1/RIPK1 expressions in amikacin-induced oxidative damage and nephrotoxicity in Wistar rats.

El Latif A, Zahra A, Badr A, Elbialy Z, Alghamdi A, Althobaiti N Toxicol Res (Camb). 2023; 12(5):979-989.

PMID: 37915468 PMC: 10615830. DOI: 10.1093/toxres/tfad091.

Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming.

Vamos E, Kalman N, Sturm E, Nayak B, Teppan J, Vantus V Antioxidants (Basel). 2023; 12(10).

PMID: 37891870 PMC: 10604361. DOI: 10.3390/antiox12101790.

The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology.

Cairns M, Joseph D, Essop M Front Endocrinol (Lausanne). 2022; 13:984342.

PMID: 36353238 PMC: 9637655. DOI: 10.3389/fendo.2022.984342.

Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress.

Santos S, Brunialti M, Rodrigues L, Liberatore A, Koh I, Martins V Biomolecules. 2022; 12(6).

PMID: 35740913 PMC: 9221060. DOI: 10.3390/biom12060788.

References

Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C . PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011; 13(4):461-468. PMC: 3086520. DOI: 10.1016/j.cmet.2011.03.004. View

Mohr S, Stamler J, Brune B . Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 1994; 348(3):223-7. DOI: 10.1016/0014-5793(94)00596-6. View

Pang J, Gong H, Xi C, Fan W, Dai Y, Zhang T . Poly(ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes. J Cell Biochem. 2010; 112(1):299-306. DOI: 10.1002/jcb.22919. View

Kim J, Devalaraja-Narashimha K, Padanilam B . TIGAR regulates glycolysis in ischemic kidney proximal tubules. Am J Physiol Renal Physiol. 2014; 308(4):F298-308. PMC: 4329488. DOI: 10.1152/ajprenal.00459.2014. View

Lieberthal W, Nigam S . Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol. 1998; 275(5):F623-31. DOI: 10.1152/ajprenal.1998.275.5.F623. View

Ha H, Snyder S . Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A. 1999; 96(24):13978-82. PMC: 24176. DOI: 10.1073/pnas.96.24.13978. View

Kim J, Long K, Tang K, Padanilam B . Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity. Kidney Int. 2012; 82(2):193-203. DOI: 10.1038/ki.2012.64. View

Park S, Yoon S, Kim J . Cisplatin induces primary necrosis through poly(ADP-ribose) polymerase 1 activation in kidney proximal tubular cells. Anat Cell Biol. 2015; 48(1):66-74. PMC: 4371183. DOI: 10.5115/acb.2015.48.1.66. View

Berger N, Berger S . Metabolic consequences of DNA damage: the role of poly (ADP-ribose) polymerase as mediator of the suicide response. Basic Life Sci. 1986; 38:357-63. DOI: 10.1007/978-1-4615-9462-8_39. View

10.

Lee J, Lim J, Kim J . Mechanical stretch induces angiotensinogen expression through PARP1 activation in kidney proximal tubular cells. In Vitro Cell Dev Biol Anim. 2014; 51(1):72-8. DOI: 10.1007/s11626-014-9809-3. View

11.

Gagne J, Isabelle M, Lo K, Bourassa S, Hendzel M, Dawson V . Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res. 2008; 36(22):6959-76. PMC: 2602769. DOI: 10.1093/nar/gkn771. View

12.

DeFronzo R, Davidson J, Del Prato S . The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab. 2011; 14(1):5-14. DOI: 10.1111/j.1463-1326.2011.01511.x. View

13.

Althaus F, Richter C . ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys. 1987; 37:1-237. View

14.

Krietsch J, Rouleau M, Pic E, Ethier C, Dawson T, Dawson V . Reprogramming cellular events by poly(ADP-ribose)-binding proteins. Mol Aspects Med. 2012; 34(6):1066-87. PMC: 3812366. DOI: 10.1016/j.mam.2012.12.005. View

15.

Zhao Y, Butler E, Tan M . Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 2013; 4:e532. PMC: 3613838. DOI: 10.1038/cddis.2013.60. View

16.

Chuang D, Hough C, Senatorov V . Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 2005; 45:269-90. DOI: 10.1146/annurev.pharmtox.45.120403.095902. View

17.

Greiner E, Guppy M, Brand K . Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem. 1994; 269(50):31484-90. View

18.

Andrabi S, Umanah G, Chang C, Stevens D, Karuppagounder S, Gagne J . Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci U S A. 2014; 111(28):10209-14. PMC: 4104885. DOI: 10.1073/pnas.1405158111. View

19.

Petrescu A, McIntosh A, Storey S, Huang H, Martin G, Landrock D . High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes. Biochim Biophys Acta. 2013; 1831(8):1412-25. PMC: 3730521. DOI: 10.1016/j.bbalip.2013.05.008. View

20.

Weber G . Enzymology of cancer cells (second of two parts). N Engl J Med. 1977; 296(10):541-51. DOI: 10.1056/NEJM197703102961005. View